Riskpilot← Back to searchSign inGet full accessBiotech Force Danmark ApS
APSActiveCVR 36434309Gl. Donsvej 6Wholesale of china and glassware and cleaning materials · NACE 4644Est. 20141 employees
Revenue 2024
DKK -2,6M
+9% vs 2023
EBITDA margin
100.0%
+78% vs 2023
Equity ratio
-96.4%
Financial strength
Net profit 2024
DKK -2,2M
+82% vs 2023
| Revenue | DKK -2,6M | +9% |
| EBITDA | DKK -2,6M | +78% |
| Net profit | DKK -2,2M | +82% |
| Total assets | DKK 14,7M | +4% |
| Equity | DKK -14,2M | -18% |
| Employees | 1 | — |
Legal name
Biotech Force Danmark ApS
CVR number
36434309
Legal form
Anpartsselskab
NACE code
4644 · Wholesale of china and glassware and cleaning materials
Founded
14. november 2014
Share capital
DKK 1.050.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen i forening.
Company purpose
Selskabets formål er udvikling, produktion og salg af desinfektions- og rengøringsmidler samt køb og salg af fast ejendom
Address
Gl. Donsvej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 596 | 1.257 | 1.589 | 3.645 | -485 | -1.485 | -1.879 | -2.965 | -2.419 | -2.648 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 596 | 1.257 | 1.589 | 3.645 | -485 | -1.485 | -1.879 | -2.965 | -11.811 | -2.648 |
| Depreciation & amort. | -245 | -1.101 | -2.155 | -1.536 | -547 | -593 | -661 | -0 | -0 | -0 |
| EBIT | 352 | 156 | -566 | 2.109 | -1.032 | -2.078 | -2.540 | -2.965 | -11.811 | -2.648 |
| Net financials | -199 | -640 | -647 | -574 | -214 | -440 | -369 | -506 | -563 | -364 |
| Profit before tax | 152 | -484 | -1.212 | 1.536 | -1.246 | -2.517 | -2.909 | -3.471 | -12.373 | -3.012 |
| Tax | 21 | -106 | -267 | 338 | -274 | -586 | -644 | -775 | -650 | -850 |
| Net profit | 131 | -378 | -945 | 1.198 | -971 | -1.931 | -2.266 | -2.696 | -11.723 | -2.162 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 21.007 | 43.146 | 49.686 | 30.508 | 21.423 | 36.177 | 34.218 | 17.023 | 14.143 | 14.734 |
| Equity | 181 | 6.291 | 5.346 | 6.543 | 5.572 | 4.640 | 2.375 | -321 | -12.044 | -14.206 |
| Long-term debt | 13.444 | 22.187 | 29.863 | 14.766 | 6.602 | 6.265 | 5.925 | 0 | 0 | 0 |
| Short-term debt | 7.165 | 12.727 | 12.804 | 7.187 | 6.932 | 22.807 | 24.097 | 16.824 | 18.708 | 22.326 |
| Total debt | 20.609 | 34.914 | 42.667 | 21.953 | 13.535 | 29.071 | 30.022 | 16.824 | 18.708 | 22.326 |
EBITDA margin
-264792200.0%
This company
15.8%
Market median
-1675900100% vs market
20152024
Equity ratio
-96.4%
This company
38.2%
Market median
-352% vs market
20152024
Return on equity
-216153100.0%
This company
18.4%
Market median
-1174745209% vs market
20152024
Net profit margin
-216153100.0%
This company
8.1%
Market median
-2668556890% vs market
20152024
Asset turnover
-0.18×
This company
1.12×
Market median
-116% vs market
20152024
Debt / equity
2.04×
This company
0.62×
Market median
-229% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-11-14 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JK Management | Management | 2025 | — | — |
NK Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Reinert Family Invest ApS | Company | 25.0% | 0.0% | 2023 |
JMR HOLDING, KOLDING A/S | Company | 25.0% | 100.0% | 2020 |
PLAN Invest A/S | Company | 25.0% | 0.0% | 2023 |
Fem Fede ApS | Company | 20.0% | 0.0% | 2023 |
NEWCO HOLDING KOLDING A/S | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PLAN Invest A/S
Biotech Force Danmark ApS Board members of Biotech Force Danmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joen-Magnus Reinert | Chief Executive Officer | 0 companies |
| Jette Kjærgaard | Management | 0 companies |
| Nina Kjærgaard Reinert | Chief Executive Officer | 0 companies |
| Anne Reinert Skovbakke | Board of Directors | 0 companies |